Aromatase inhibitors as adjuvant therapy: how will results of the ATAC trial at San Antonio 2004 and BIG 1-98 at St Gallen 2005 impact on aromatase inhibitors as adjuvant endocrine therapy?

N. S. Wong

首页> 外文期刊>Breast cancer online: BCO >Aromatase inhibitors as adjuvant therapy: how will results of the ATAC trial at San Antonio 2004 and BIG 1-98 at St Gallen 2005 impact on aromatase inhibitors as adjuvant endocrine therapy?

【24h】

Aromatase inhibitors as adjuvant therapy: how will results of the ATAC trial at San Antonio 2004 and BIG 1-98 at St Gallen 2005 impact on aromatase inhibitors as adjuvant endocrine therapy?

机译：芳香酶抑制剂作为辅助治疗：2004年圣安东尼奥市的ATAC试验和2005年圣加仑的BIG 1-98试验结果将如何影响芳香酶抑制剂作为辅助内分泌治疗？

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Breast cancer online: BCO》 |2005年第12期|共页
作者
N. S. Wong;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor plus breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：NRG肿瘤学的十年结果/ NSABP B-42：延长佐剂内分泌治疗的随机，双盲，安慰剂对照临床试验，延长佐剂内分泌治疗，含有激素受体加乳腺癌（BC）的绝经后妇女用芳香酶抑制剂（AI）完成了先前的佐剂治疗
2. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial. [J] . Forbes JF Seminars in Oncology . 2006,第2Suppla7期

机译：早期辅助芳香化酶抑制剂治疗的使用：BIG 1-98来曲唑试验的贡献。
3. Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42 [J] . Mamounas E., Bandos H., Lembersky B., The Breast : . 2017,第期

机译：延长辅助内分泌治疗与芳香酶抑制剂（AI）后辅助治疗后患有激素受体（+）乳腺癌的绝经后妇女的延长辅助内分泌治疗的影响（+）乳腺癌（AI）：NRG肿瘤学/ NSABP B-42
4. Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience [C] . World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：乳腺癌患者辅助芳香化酶抑制剂治疗期间的骨密度变化：单中心经验。
5. Musculoskeletal symptoms in women on aromatase inhibitors for adjuvant breast cancer therapy. [D] . Olufade, Temitope. 2012

机译：妇女在芳香酶抑制剂上的肌肉骨骼症状可用于辅助性乳腺癌治疗。
6. Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial [O] . G. Viale, M. M. Regan, P. DellOrto, -1

机译：哪些患者从辅助芳香化酶抑制剂中受益最大？在BIG 1-98随机试验中使用综合评估预后风险的结果
7. Aromatase inhibitors as adjuvant therapy: how will results of the ATAC trial at San Antonio 2004 and BIG 1-98 at St Gallen 2005 impact on aromatase inhibitors as adjuvant endocrine therapy? [O] . N. S. Wong, K. I. Pritchard 2005

机译：芳香酶抑制剂作为佐剂疗法：如何在San Antonio 2004和ST Gallen 2005对芳香酶抑制剂对芳族酶抑制剂的影响结果进行ATAC试验的结果如何促成佐剂内分泌治疗？

Aromatase inhibitors as adjuvant therapy: how will results of the ATAC trial at San Antonio 2004 and BIG 1-98 at St Gallen 2005 impact on aromatase inhibitors as adjuvant endocrine therapy?

著录项

引文网络

相似文献

相关主题

期刊订阅